These results indicated that rLZ-8 can increase the number of peripheral blood WBCs in mice with neutropenia and can achieve same or better therapeutic effects as compared to the recommended injection dosage of G-CSF. This evidence concerns the gene CSF3 and Decreased total neutrophil count.